Protagonist Therapeutics Market Sentiment

Protagonist Therapeutics Inc

PTGXNASDAQ

Trade with Public

$137.97

-1.56-1.11%

마지막 업데이트: Oct 23, 2:04 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Protagonist Therapeutics Market Sentiment - Benzinga

Protagonist Therapeutics Market Sentiment

Market sentiment signals for Protagonist Therapeutics (PTGX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 16.8% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

20 analysts

Options Flow (P/C)

0.00

More calls — Bullish

42 calls · 0 puts

Avg Consensus PT

$138

+0.0%

Highest Price Target

$190

+37.7%

BMO Capital

Lowest Price Target

$38

-72.5%

Goldman Sachs

Short Interest

16.8%

Rising — Bearish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	TD Cowen	Tara Bancroft—	+16.0%	$155 → $160	Maintained	Buy
Oct 12, 2026	UBS	Alice Nettleton—	+33.4%	$184	Initiate	Buy
Oct 12, 2026	Leerink Partners	Will Soghikian—	+37.7%	$150 → $190	Assumes	Outperform
Sep 1, 2026	Barclays	Etzer Darout—	+30.5%	$153 → $180	Maintained	Overweight
Sep 1, 2026	BMO Capital	Etzer Darout—	+37.7%	$178 → $190	Maintained	Outperform
Aug 31, 2026	Citigroup	Geoff Meacham—	+31.9%	$175 → $182	Maintained	Buy
Aug 31, 2026	HC Wainwright & Co.	Douglas Tsao—	+23.2%	$167 → $170	Maintained	Buy
Aug 17, 2026	BMO Capital	Etzer Darout—	+29.0%	$112 → $178	Maintained	Outperform
Aug 10, 2026	Truist Securities	Srikripa Devarakonda—	+23.2%	$145 → $170	Maintained	Buy
Aug 10, 2026	Wedbush	Yun Zhong—	+25.4%	$118 → $173	Maintained	Outperform
Aug 10, 2026	Goldman Sachs	Richard Law—	+34.8%	$110 → $186	Upgrade	Neutral→Buy
Aug 6, 2026	Citigroup	Geoff Meacham—	+26.8%	$130 → $175	Maintained	Buy
Aug 6, 2026	Barclays	Etzer Darout—	+10.9%	$151 → $153	Maintained	Overweight
Jul 14, 2026	Barclays	Etzer Darout—	+9.4%	$119 → $151	Maintained	Overweight
Jul 7, 2026	Truist Securities	Srikripa Devarakonda—	+5.1%	$121 → $145	Maintained	Buy
May 10, 2026	Citigroup	Geoff Meacham—	-5.8%	$125 → $130	Maintained	Buy
May 6, 2026	Citizens	Jonathan Wolleben—	-0.7%	$120 → $137	Maintained	Market Outperform
May 6, 2026	Wedbush	Yun Zhong—	-14.5%	$112 → $118	Maintained	Outperform
Apr 15, 2026	Truist Securities	Srikripa Devarakonda—	-12.3%	$110 → $121	Maintained	Buy
Apr 7, 2026	Clear Street	Kaveri Pohlman—	-15.9%	$104 → $116	Maintained	Buy
Mar 19, 2026	Leerink Partners	Faisal Khurshid—	-20.3%	$107 → $110	Maintained	Outperform
Mar 19, 2026	JP Morgan	Brian Cheng—	-23.2%	$95 → $106	Maintained	Overweight
Mar 19, 2026	Citigroup	Geoff Meacham—	-9.4%	$115 → $125	Maintained	Buy
Mar 19, 2026	Barclays	Etzer Darout—	-13.8%	$113 → $119	Maintained	Overweight
Mar 3, 2026	Goldman Sachs	Richard Law—	-31.1%	$65 → $95	Maintained	Neutral